CD274 and renal cell adenocarcinoma: Of note, PD-L1 expression on tumor cells has been shown to correlate with poor prognosis in patients with RCC (Fig. 2) 34, MEL, and breast, pancreatic, stomach, bladder, lung, liver, and ovarian cancers (Table 2) 33,35–38.